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heart connection. Finally, we propose a new look at
SD risk factors considering both brain and heart in
their association with SD, and review strategies for
prevention of SD from this perspective.
Introduction

Abstract
During the past 30 years, rate of coronary artery
disease (CAD), as the main cause of sudden death
(SD), has decreased more than rate of SD. Likewise,
cause of SD remains elusive in not a trivial portion of
its victims. One possible reason is attention to only
one organ, the heart, as the cause of SD. In fact, SD
literature focuses more on the heart, less on the
brain, and seldom on both. A change is required. In
this paper, we first review the pathological findings
seen in heart autopsies of SD victims after
psychological stressors such as physical assault
victims without internal injuries. Then, we
summarize new studies investigating brain areas, like
the insula, whose malfunctions and injuries are
related to SD. Next, we review prototypes of
neurological diseases and psychological stressors
associated with SD and look at heart failure
(HF)-related SD providing evidence for the brain-

Sudden death (SD) or sudden cardiac death (SCD)
is defined as an unexpected death occurring within
1 or 24 hour(s) of symptoms onset and without
obvious non-cardiac causes such as end-stage
obstructive lung disease, intoxication, or severe
trauma.1 It is estimated that between 180000 to
450000 SDs happen annually in the United States
(US).2 The variations in estimates reflect different
SD definitions and methodologies used in the
studies.2 Using the multiple source surveillance
method, studies have reported SD incidences from
40 to 100 per 100000 inhabitants in the US,3
Germany,4 Ireland,5 and China.6
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Studies looking at trends of SD incidence
showed that it has decreased in the past 30 years,
but to a less extent than the decrease seen in the
death rate due to coronary artery disease (CAD)
which is the main cause of SD.7,8
SD starts from sudden cardiac arrest which
results in SD when attempts for resuscitation are
unsuccessful. This happens in 90% of cardiac
arrests occurring in the community.9 Survivors are
recommended to undergo thorough investigations
for finding the etiologies enabling physicians to
protect them against recurrence.10 Looking at the
mentioned etiologies listed in such papers and
guidelines,1,10,11 we do not find a nervous system
disorder as a potential cause nor do we find a
recommendation for a neurological consultation
after surviving cardiac arrest. In fact, studies that
examined systematically sudden cardiac arrest
survivors by exclusive investigation for covert
heart diseases could not find the cause in up
to 50% of survivors,12 implying a possible role for
brain and nervous system diseases and/or
their interactions.
In this paper, we first look at human studies
showing cardiac damage after brain lesions or
psychological or physical stress. Second, we
summarize clinical studies looking for brain areas
whose injuries affect the heart’s electrical and
mechanical health. Third, we examine neurological
brain diseases (such as stroke and epilepsy) and
psychological conditions (such as stressful life
events) associated with an increased risk of SD.
Fourth, we look at a heart condition [heart failure
(HF)] providing evidence for the brain-heart
connection in SD. Finally, we mention strategies for
the prevention of SD, from the perspective of the
brain-heart interactions in SD.
Heart biopsies and post-mortem findings
Reliable and interesting evidence for the
brain-heart connection comes from studies that
have performed histopathological examinations of
hearts of patients after sudden emotional stress or
victims of physical assault who died without gross
internal injuries. In a report of 19 patients with
takotsubo cardiomyopathy (TCM) [median
ejection fraction (EF): 0.2 odds ratio (OR)
20%. Interquartile range (IQR): 0.15 to 0.30]. Only
one of them had angiographic evidence of a
luminal narrowing of 70 percent and none of them
had a significant coronary spasm.13 Five of them
underwent endomyocardial biopsy which showed
extensive lymphocyte infiltrates with contraction

band necrosis in one of the patients and
macrophage and lymphocyte infiltrates with
contraction bands but without myocyte necrosis in
the other four.13 In examining 15 victims who died
as a direct result of physical assaults but without
internal injuries, myofibrillar degeneration was
found in the hearts of 11 victims, which is the
pathology
described in stressed animal
experiments.14 Such changes were not found in the
age-matched controls. Of note, two of the victims
with the described lesions survived the attack but
suffered from arrhythmias throughout the hospital
course.14 The contraction band necrosis has also
been reported in a young Japanese woman who
escaped from her boyfriend’s violence, ran 150
meters, and suddenly collapsed.15
Subarachnoid hemorrhage (SAH) is another
potential cause of SD. In an autopsy report of
3 patients with SAH with electrocardiography
(ECG) changes, the post-mortem examination
revealed
several
petechial
subendocardial
hemorrhages (SEH).16 In another report from
9 patients with SAH, cardiac lesions were seen in all
of them that ranged from eosinophilia with
preservation of cross-striations to transformation of
the myocardial cytoplasm into dense eosinophilic
transverse bands with intervening granularity
sometimes coupled with endocardial hemorrhage.17
From the pathological point of view, sharp
differences exist between coagulative necrosis,
lesions seen in myocardial infarction (MI) after
coronary occlusion, and cardiac lesions seen due to
catecholamine damage with peroxidation.18,19 The
latter is called by different terms such as contraction
band necrosis, myofibrillar degeneration, and
coagulative myocytolysis, and is reported in victims
of physical assaults without internal injury and in
patients with CAD in whom helplessness and
hopelessness were the basic feelings. In coagulation
necrosis, cells die in a relaxed state without
prominent contraction bands and the changes are
not visible until several hours or days later. The area
is infiltrated by polymorphonuclear cells and
calcification occurs late. In contrast, in contraction
band necrosis, cells die in the hypercontracted state
with prominent contraction bands, mononuclear
cells are the predominant cell infiltrates,
calcification may happen immediately, and changes
are seen within minutes of onset. Apart from
necrosis, other pathological findings have also been
correlated with catecholamine toxicity, including
myocardial cells’ disarray.
As
contraction
band
necrosis
occurs
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predominantly in the subendocardial area, it can
affect the cardiac conduction system and increase
the risk of fatal arrhythmias, specifically when we
note a propensity of catecholamines to evoke
arrhythmias by themselves, even in a normal heart.
In fact, this mechanism may underlie many
apparently unrelated cases of SD following
neurological diseases such as epileptic seizure,
SAH, and ischemic stroke, or SD during grief for a
loss and when frightened to death.
Brain regions associated with heart function
The field of neurocardiology started with the
observations and experiments of the French
physiologist Claude Bernard who was the first to
describe reciprocal interactions between the heart
and the nervous system.20 The American
physiologist Walter Bradford Cannon highlighted
that severe emotional stress might have fatal
consequences.21 He summarized reports of voodoo
death - SD due to intense emotions, often fear, in
native societies - and suggested that cardiovascular
shock following a hyperactivation of the
sympathetic nervous system (SNS) might be the
underlying pathological mechanism.
Research on the functional neuroanatomy of the
autonomic nervous system and its interactions with
the cardiovascular system has traditionally focused
on autonomic circuits at the spinal and brainstem
level and peripheral neurotransmitters such as
acetylcholine22 and norepinephrine.23 More recently,
several lines of observational and experimental
evidence have suggested that a widespread brain

cortical and subcortical circuitry is involved in the
control of the autonomic nervous system, the central
autonomic network.24 Several converging lines of
evidence have identified the core regions of the
central autonomic network: the bilateral insular
cortex, prefrontal cortex (PFC), anterior cingulate
cortex (ACC), amygdala, and hypothalamus
(Figure 1).24 The hypothalamus (Figure 1) is
well-known to be involved in the autonomic nervous
system control as sympathetic nerves originate from
its nuclei, and will not be discussed here.
The insular cortex (Figure 1) is an area
specialized in sensory, cognitive, affective, and
autonomic integration25-27 and, therefore, is
regarded as a principal hub of the central
autonomic network.28 Evidence for the important
role of the insula in autonomic regulation is
provided by lesion studies, cortical stimulation,
and functional neuroimaging. Lesions of the
insular cortex, e.g., due to ischemic stroke or
intracerebral hemorrhage (ICH), often result in
autonomic imbalance, consecutive myocardial
damage,
and
cardiac
arrhythmias.29,30
Intraoperative cortical stimulation of the left
insular cortex causes primarily bradycardia and
depressor responses, whereas stimulation of the
right insular cortex is often associated with
tachycardia and pressor responses.31 Studies using
functional magnetic resonance imaging (MRI)
have demonstrated insular activation during
different autonomic challenges, such as cognitive
tasks, emotional stimulation, exercise, the Valsalva
maneuver, and the cold pressor test.32,33

Figure 1. Core areas of the central autonomic network; it includes the insula (red), the anterior cingulate cortex (ACC)
(green), the medial prefrontal cortex (PFC) (yellow), the amygdala (blue), and the hypothalamus (purple). The image
shows the Montreal Neurological Institute (MNI) 152 T1 1mm template (as provided by FSL). To locate the
anatomical areas, the Talairach atlas (for the hypothalamus) and the Harvard-Oxford cortical structural atlas (for all
other areas) were used (as included in FSLeyes).
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Clinical and neuroimaging studies have shown
that the ANS is also modulated by parts of the PFC,
in particular, the orbitofrontal and the medial PFC
(Figure 1).34 In a study of hand-grip exercise, more
intense exercise and increased heart rate were
associated with a deactivation of the ventromedial
PFC (vmPFC), suggesting that parasympathetic
efferents to the heart are mediated by the PFC.35
Moreover, the vmPFC regulates the activity of the
amygdala (Figure 1), which is a brain area involved
in emotions, such as fear. In fact, the central
nucleus of the amygdala is involved in the
modulation of the ANS. In humans processing
fearful faces, activity in the right amygdala was
positively correlated with heart rate.36
Another brain region of interest is the ACC
(Figure 1) which is a critical interface between the
motor system, cognition, emotion, and autonomic
functions.37 During cognitive demanding tasks,
evidence for modulation of the sympathetic and
parasympathetic tone was found in the dorsal
ACC.38,39
SD in brain diseases
Acute
stroke:
Myocardial
injury,
ECG
abnormalities, and cardiac arrhythmias are
frequent sequelae following acute stroke, even in
patients without pre-existing heart disease. In a
prospective study on 2123 patients with acute
ischemic stroke (AIS), using a high-sensitivity
troponin assay, 13.7% had elevated troponin
concentrations in the acute phase.40 Interestingly,
in a subgroup of patients with acute stroke who
underwent coronary angiography, half of the
patients had no angiographic evidence of CAD.40
In a meta-analysis done on 2901 patients across
15 studies, including patients with ischemic and
hemorrhagic stroke, 18.1% [95% confidence interval
(CI): 13.6%-22.6%] had elevated troponin
concentrations.41 Several lines of evidence suggest
that an ischemic or hemorrhagic lesion, in particular
involving the right insular cortex, may result in
autonomic imbalance, leading to increased
catecholamine secretion and finally, to diffuse
myocardial injury known as myocytolysis.42
Irregularities of cardiac depolarization and
repolarization are frequently detected on ECGs of
patients with acute stroke. In a study on 279
patients with AIS, prolonged QTc interval (36%),
ST depression (24.5%), and T wave inversion
(17.8%) were seen at admission.43 QT
prolongation44 and ST elevation45 at admission
were associated with ischemic lesions of the insula.

Serious arrhythmias, such as ventricular or
supraventricular
tachycardia,
sinus
node
dysfunction, bradyarrhythmia, or atrioventricular
(AV) block II and III were found in 25.1% of 501
patients with acute ischemic or hemorrhagic stroke
during the first 72 hours after admission.46 In
another prospective study on 332 stroke patients,
who were monitored for at least 48 hours, 29.5% of
all patients had significant arrhythmias with
tachyarrhythmias being more frequent than
bradyarrhythmias (27.1% vs. 3.9%).47 A significant
association was found between the incidence of
serious arrhythmias in the acute phase of stroke
and a lesion involving the insula, frontal cortex,
parietal cortex, amygdala, thalamus, or basal
ganglia of the right hemisphere.48 In a subgroup of
stroke patients, fatal or near-fatal arrhythmias,
primarily ventricular tachycardias rapidly
evolving to ventricular fibrillation (VF), may occur,
leading to SCD.49 The exact mechanism of ECG
alterations and serious arrhythmias after stroke is
complex and multifactorial, probably including
autonomic dysfunction and myocardial injury,
modulated by genetic susceptibility and the
cognitive and emotional situation of the
patient.50,51 Due to the potentially life-threatening
cardiac complications following acute stroke,
clinical guidelines recommend cardiac diagnostics
including ECG and cardiac markers at admission
and continuous cardiac monitoring for at least
24 hours after the event.52 Additional studies on
the interplay between ischemic stroke and heart
disease are urgently needed, involving functional
MRI53 and analysis of genetic variants associated
with arrhythmias.
SAH: SAH is a devastating neurological
condition that usually results from an unexpected
sudden rupture of a berry cerebral aneurysm. It is
well known to be associated with SD; in a
nationwide SAH incidence study in Finland, one
fourth of victims had SD before reaching any
hospital ward.54
Elevation of cardiac injury markers is common
after SAH. ECG changes have been reported in
about two thirds of SAH hospitalized patients;55,56
the most common changes were prolonged QT
interval followed by T waves inversion and ST
depression or elevation,55-57 and they predicted
higher in-hospital mortality.56 Besides, cardiac
troponin was increased in 30% of patients with
SAH and was associated with an increased risk of
in-hospital mortality and 12-month deaths.58
Mechanisms connecting SAH to cardiac injury and
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SD are unclear, but rupture of posterior circulation
aneurysms was more commonly associated with
SD,59 possibly because of vital heart-connected
centers located in the brainstem and supplied by
the posterior circulation.
Epilepsy: Several community-based studies
have demonstrated that patients with epilepsy have
an approximately threefold increased risk of SCD
(with documented ECG abnormalities, such as
ventricular tachyarrhythmia or VF).60 The studies
also indicate that the age of patients with sudden
unexpected death due to epilepsy (SUDEP) is
significantly lower than of those without epilepsy
(55 ± 25 vs. 63 ± 19 years, P < 0.001), indicating a
distinct pathology and etiology.61 SUDEP is defined
as a sudden, unexpected, nontraumatic and
nondrowning, witnessed or unwitnessed death in
patients with diagnosed epilepsy, with or without
evidence of an acute seizure, and excluded status
epilepticus (SE), with unrevealing post-mortem
examination.62 Currently, SUDEP is considered the
leading cause of death in patients with
epilepsy.60,63 Several risk factors have been
reported for SUDEP including young age (15-20
years), poor seizure control, use of sodium-channel
blockers as antiepileptic drugs, refractory epilepsy,
multiagent therapy, seizure types (tonic-clonic
seizure), early-life epilepsy, and cardiovascular
disease (CVD) including the presence of ischemia,
previous atrial or ventricular arrhythmias, and
history of cardiovascular events.60,64
The exact mechanism of SUDEP has not been
determined; however, the main etiology of SUDEP
is atrial and ventricular arrhythmias during
epilepsy in the context of a previously diseased
and susceptible heart.65 The observation that
patients with epilepsy have a worse cardiovascular
profile66 and a higher risk of cardiovascular events
and arrhythmias compared with the normal
population67 indicates that epilepsy and CVDs
might share a congenital and genetic basis
affecting both the heart and brain. In brief, the
epileptic discharges are associated with episodes
of central autonomic imbalance with sympathetic
dominance, leading to repetitive episodes of
apnea, hypoxemia, and cardiac injury. Li et al.
postulated that ictal discharge originating from the
cortex could, primarily or secondarily, involve the
insular lobe through epileptogenic signal
networks,
leading
to
cardiorespiratory
dysfunction, central apnea, arrhythmias, and
SUDEP.68 Accordingly, Nayak et al. also
postulated that autonomic imbalance determined

44

by changes in heart rate variability (HRV) during
epilepsy might be the main mechanism of
SUDEP.69 They demonstrated that in patients with
refractory temporal lobe epilepsy (TLE), a lack of
apnea-mediated HRV changes existed, leading to
an alteration in baroreceptor reflex activation,
predisposing them to SUDEP.69
Sleep apnea: One metric to define sleep apnea
and its severity is the apnea-hypopnea index
(AHI), derived from polysomnographic (PSG)
recordings.70 This index represents the average
hourly frequency of apnea (airflow absent > 10
seconds) plus hypopnea [airflow diminution
associated with a drop in arterial oxyhemoglobin
saturation (SaO2) ≥ 3% or terminated by an
electroencephalographic (EEG) arousal] during
sleep. AHI less than 5 per hour is normal, and
severe SA is considered when AHI is > 30 per
hour.71 sleep apnea is classified into obstructive
sleep apnea (OSA) and central sleep apnea (CSA)
according to the presence of obstruction and/or
resistance to airflow in the upper airways.
Sleep apnea was first considered as a possible
diagnosis in patients complaining of excessive
daytime sleepiness (EDS). Later epidemiological
studies revealed an association between sleep apnea
and cardiovascular events including SD.70 Patients
with OSA were more than twice susceptible to
experience SD from midnight to 6:00 AM compared
to the general population and patients without
OSA.72 Following more than 10000 participants for
an average of 5.3 years, investigators found the
lowest nocturnal oxygen (O2) saturation, decreased
in patients with OSA, as an independent SCD risk
factor besides hypertension (HTN), CAD, and HF.73
Congruent with more SD risk in patients with
sleep apnea, arrhythmias such as atrial fibrillation
(AF) and complex ventricular ectopy were more
frequent among patients with sleep apnea.
Interestingly, appropriate implantable cardioverterdefibrillator (ICD) therapy was 4 times more
frequent when ICD patients had sleep-disordered
breathing (SDB), defined as AHI > 10, and the
difference was only seen during sleep hours from
midnight to 6:00 AM.74
Mechanistically, excessive sympathetic and
parasympathetic activity is seen in patients with
sleep apnea and links sleep apnea to cardiovascular
events and SD. Cessation of breathing results
in an increased sympathetic outflow through
different mechanisms such as stimulation of
chemoreceptors by O2 desaturation, carbon
dioxide (CO2) increase, and silencing pulmonary
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stretch receptors. Such an overactive sympathetic
state persists even after termination of an apnea
episode which does not last beyond 90 seconds. In
fact, patients with sleep apnea showed structural
changes in the brain areas associated with the
autonomic nervous system such as the insula and
cingulate cortex and the changes were associated
with O2 desaturation.75
Other brain diseases: In a population-based
autopsy study of consecutive SDs, neurological
diseases were the most common non-cardiac
causes of SD after drug overdose, and they
comprised 5% of SDs.76 Intracranial hemorrhage
and SUDEP were the most common causes of the
neurological SDs, followed by SAH, AIS, and
Huntington’s disease (HD), which is an inherited
disease of abnormal movements with concomitant
psychiatric and cognitive manifestations. One of
the SD victims had an ICD and interrogation of the
defibrillator demonstrated that the patient had
been repeatedly shocked for VF, but the autopsy
revealed that the cause of SD was SAH.76 Other
brain diseases (Table 1) have also been mentioned
to be associated with SD including Parkinson’s
disease (PD), multiple sclerosis (MS), and brain
tumors, such as meningioma. For instance,
demyelinating lesions of MS may affect the
medulla oblongata, which has cardiac innervating
nuclei, and cause SD. Although many of the
neurological diseases can precipitate SD through
involvement of the peripheral nervous system
(PNS) including the muscles, like myotonic
dystrophy type 1 (DM1), they are not discussed in
this review, and can be found elsewhere.77
Table 1. Brain diseases accounted for sudden
death (SD)
More commonly accounted
ICH
Epilepsy
AIS
SAH
Sleep disorders (e.g., OSA,CSA)
Multiple system atrophy
Less commonly accounted
MS
PD
Brain tumors
HD
Friedreich ataxia
Migraine
ICH: Intracerebral hemorrhage; AIS: Acute ischemic
stroke; SAH: Subarachnoid hemorrhage; OSA:
Obstructive sleep apnea; CSA: Central sleep apnea;
MS: Multiple sclerosis; PD: Parkinson’s disease; HD:
Huntington’s disease

Psychological stress and SD
History of stress and SD: “There is no evidence that
stress causes heart disease, nor will there ever be”.
This sentence was an explicit opinion addressed
30 years ago by the chair of a panel organized by an
Australian national health body to review the
association of mental stress and CVD.78 However, a
strong resurgence is seen among researchers and
clinicians to support the idea of an association
between psychological stress and heart diseases,
dating back to 1628 and expressed by William
Harvey by his description of angina of emotion.79
In 1942, Walter B Cannon published one of the
earliest remarkable papers about the association
between stress and SD, “voodoo death”, where he
recounted anecdotal experiences of death from
fright.21 Cannon found that all the recounted
experiences had at least one common feature: they
were induced by an absolute belief that an external
power, such as a wizard, could cause their demise
deliberately, and the victims did not have any
power to prevent death. Newer studies have
shown an increased risk of SD, not non-sudden
coronary death or nonfatal CAD, in people who
had reported higher levels of phobic anxiety.80
Earthquakes as stressors: Earthquakes are one
of the acute stressors during which many papers
have demonstrated increased cardiovascular
risk.81 After a major earthquake in Athens, Greece,
in 1981, an excess of mortality was observed
during the first few days compared with the same
periods in 1980 and 1982.82 The mortality excess
was due to cardiac and external causes, while no or
few increased deaths were seen due to cancer and
other causes, respectively. Los Angeles, USA, was
jolted by an earthquake on January 17, 1994, at 4:31
AM. From 101 recorded deaths on this day, 51 were
attributed to atherosclerotic cardiovascular causes,
which was more than five times the number of
cardiovascular deaths in the preceding week, and
relative risk (RR) of death due to atherosclerotic
heart disease was 2.6 (1.8-3.7) compared with the
same periods in previous years.83 Of note was the
time of death: midnight to 6 AM was the time of
death in 54% of atherosclerotic deaths occurred on
the day of the earthquake compared to 9% of the
deaths during 7 days before the earthquake.
A study on subjects who were wearing 24-hour
Holter ECG monitors during the Taiwan
earthquake
in
1999
showed
autonomic
dysregulation during the earthquake.84 HRV study
showed that sympathetic overactivity was present
in 9 out of 12 patients, and was absent in three
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others who were consuming beta-blockers.
Athletic games as stressors for spectators: One
of the first reports in this area was about
cardiovascular events among German residents
during a soccer World Cup held in Germany in
2006.85 The authors found that cardiovascular
events had been increased with the highest rise in
arrhythmia events. The rise was also more profound
in men and during days on which the German
soccer team was playing. Such an increase in
cardiovascular events, including SD, has been
reported in spectators of other sports such as
football,86 hockey,87 and baseball.88 By contrast,
some studies have not found any increase in
cardiovascular events during a championship
series.89 Although differences in study design can
explain part of this heterogeneity, the results of
other studies showed that people were not at the
same risk of increased cardiovascular events while
watching athletic games. Men are usually at higher
risk;85,87 age is an important factor and in some
reports, younger87 and in others, older people88
were at higher risk. Live watching was also
associated with a higher risk compared to televised
watching.90 Autonomic imbalance seems to play a
major role in the increased risk of cardiovascular
events as studies showed a 110% increase in heart
rate90 and increased serum levels of noradrenaline91
during game watching.
War and terrorist attacks as stressors: In the
first week of Iraqi missile attack on Israel, the
incidence of MI and SD increased among Israeli
civilians, but returned to its normal rate after the
first week despite the continuation of missile
attacks.92 In another war report from Zagreb,
Croatia, in 1991, MI and its mortality increased
during the war compared to control periods. The
incidence of MI increased three times in the first 48
hours following the terrorist attack of the New
York World Trade Center, USA, on September
11, 2001, and returned to normal levels thereafter.93
Moreover, studies with patients who had ICDs
showed an increased incidence of ventricular
tachyarrhythmias in the first 30 days following the
September 11th attack.94 Of note, tachyarrhythmias
increased not only among residents of the New
York area,94 but also in patients living in Florida,
USA,95 far from the attack, highlighting the role of
psychological, not physical, stress as the risk factor
for the arrhythmias.
Pleasant emotions and SD: An excess of SD
after natural disasters and during major sporting
events has been well documented. However,

46

pleasant events can also be associated with
undesirable outcomes. It has been shown that the
one day of the year in which someone is more
likely to have a heart attack or a stroke is one’s
birthday.96 The association of a usually pleasant
event, such as a birthday, with adverse outcomes
suggests that the physiological underpinnings of
strong emotions are similar. Some evidence for this
comes from the realization that TCM can occur not
only after bad news, but also after pleasant
surprises, such as winning the lottery.97 No one can
be prepared for the eventualities of life, but
awareness about the risks of strong emotions may
be a first step in preventing or mitigating them.
TCM: Another piece of evidence for the
association between stress and heart disease comes
from examining survivors of TCM. Recent studies
have found injury to the insular cortex to be
associated with the incidence of TCM.98,99 In a
Korean multicenter stroke registry, 23 patients
with ischemic stroke had imaging characteristics of
TCM from 5098 patients with ischemic stroke
without any history or imaging evidence for CAD.
Stroke lesions in the TCM patients involved the
insular cortex more often than other brain
regions.99 In a single-center registry study of
cardiology patients, 6 patients had experienced an
ischemic stroke (n = 4) or epileptic seizures (n = 2)
in the 2 days preceding the onset of the TCM.98
They arrived at the hospital because of their
neurological complaints and had normal ECG on
admission. After a few hours, they developed ECG
changes, e.g., ST-segment elevation while only 2 of
them presented with chest pain, and were
diagnosed to suffer from TCM. Insular lesions
were seen in 4 of the 6 patients.98 Therefore,
abnormalities in the brain regions associated with
the autonomic control, such as insular cortex, may
have a role in predisposing victims of TCM to
emotional and physical stressors. In future studies,
structural and functional MRI of the brain should
be performed in patients with TCM.
Another neurological condition associated with
TCM is seizure. Approximately, 50 case reports
have been published describing TCM after
seizures.100 Both generalized and focal seizures as
well as SE have been described as types of seizures
associated with TCM, and TCM has been cited as a
reason for SUDEP. In a recently published study
leveraging National Inpatient Sample databases,
investigators found 1 in every 1000 epilepsyrelated hospitalization in the US to be associated
with TCM, which had increased in-hospital
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morbidity and mortality of epilepsy patients.101
Compared to TCM unrelated to seizures,
seizure-related TCM is associated with much less
chest pain, more cardiogenic shocks, and a much
higher recurrence rate.102 Therefore, cardiologists
should be involved in the management of
hospitalized epilepsy patients who may develop
TCM without any cardiac symptom. In addition,
more studies are needed to risk stratify epilepsy
patients who will develop or re-experience TCM.
Brain-heart connection in HF-related SD
SD is a major cause of death in patients with HF,
and ICDs are recommended in the HF guidelines
for its prevention.69
Autonomic nervous system imbalance exists in
HF although not every HF patient has it. It manifests
as an increased sympathetic and attenuated
parasympathetic nervous system activity. The
autonomic nervous system imbalance leads to
structural changes in cardiac muscles including
myocyte dysfunction caused by excessive
β-adrenergic receptor (βAR) stimulation with
apoptosis and βAR desensitization, altered kinase
and phosphatase activity, neurohumoral activation,
increased susceptibility to arrhythmia, inflammation,
and abnormal nitric oxide synthase (NOS) signaling,
all of which lead to a worse clinical outcome and
reduced survival in patients with HF.103 Clinical
studies showed autonomic nervous system
imbalance to be a risk factor for SD in patients with
HF and to be also associated with exercise
intolerance, disease progression, and pump failure.103
Both central nervous system (CNS) and PNS
dysfunctions are involved in the development of

autonomic nervous system imbalance. In the brain,
structural and functional changes are seen in areas
related to autonomic control. A recent study
demonstrated that patients with chronic HF had
altered neural activation in multiple autonomic and
motor control areas, including cerebellar
hemispheres, vermis, left insula, left putamen, and
bilateral postcentral gyrus. Structural brain changes
emerged in similar autonomic, as well as cognitive
and mood regulation areas.104 These studies indicate
that the functions of insular and cerebellar regions,
sites that are involved in autonomic regulation, are
compromised, and that autonomic nervous system
imbalance has a brain structural and functional
basis too. In fact, it has been demonstrated that
without apparent effect on left ventricular EF
(LVEF), early subclinical cardiac dysfunction and
brain abnormalities are present and associated in
middle-aged generally healthy individuals.105 This
demonstrates that structural and functional changes
of the brain outpace the clinical HF and ventricular
dysfunction could be explained by the autonomic
nervous system imbalance before overt HF.105 Thus,
autonomic nervous system imbalance can be a
therapeutic target for declining SD in HF, and we
expect to see new horizons and perspectives soon.
Prevention of SD
CAD is the most common cause of SD followed by
HF with fatal arrhythmia as the main direct reason
of death in both. Identification of SD risk factors
(Figure 2) can help to identify patients with
increased risk and to promote the development of
preventive strategies.

Figure 2. Selected sudden death (SD) risk factors in light of heart-brain connection; more common risk factors
are summarized and classified here. Other SD risk factors can be found in the text and elsewhere.69
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Drug
addiction106
and
demographic
107
variables are among risk factors that increase
SD risk by affecting the brain, heart, or both.
Many cases of SUDEP or stroke are related to
existing cardiac disorders;49,108 however, SD can
also occur in stroke or epilepsy patients with a
structurally normal heart.
While many patients with epilepsy and their
relatives want education sessions, unfortunately,
fewer than 15% receive systematic education on
SUDEP.109 Whether to inform the patients about
SUDEP is still argued by some physicians, and
increasing awareness is recommended in most
recent publications.110 Another preventive
measure is seizure control, shown to prevent
SUDEP, but using seizure alert devices and antisuffocation pillows may help too. Other preventive
strategies against SUDEP are a timely referral for
surgical evaluation in patients with intractable
epilepsy, detecting cardiorespiratory distress
through clinical observation, O2 administration,
and using respiratory and heart rate monitoring
devices, particularly during sleep. Besides, use of
drugs that enhance the serotonergic mechanisms
of respiratory regulation [e.g., selective serotonin
reuptake inhibitors (SSRIs)], decrease endogenous
opioid-induced brain and brainstem depression, or
inhibit adenosine receptors may be other effective
preventive measures.111 However, further high
quality researches and investigating the
appropriate use of pacemakers and ICDs in the
patients with epilepsy are warranted.
Cardiac dysfunction following stroke is
common, but its prevention needs a more detailed
understanding of its complex mechanisms.49 In
most cases of SD following ischemic stroke, cardiac
arrhythmia, myocardial injury in the presence or
absence of CAD, and autonomic imbalance are
contributing factors.49 Defining the predictors of
SD after stroke may help to develop preventive
actions, but there is no systematic approach and no
strong evidence to define them. However,
identifying stroke locations in addition to cardiac
abnormalities might be helpful in the identification
of patients with high risk for SD. Some of the
cardiac abnormalities are presence of HF, markers
of acute myocardial injury, and cardiac conduction
disorders, specifically QT prolongation. Studies in
the area of genetic variants that are the underlying
reasons for lethal arrhythmias related to
autonomic dysfunction seem to be necessary to
develop further preventive strategies.48
Irrespective of the EF level, arrhythmic SD is
responsible for many deaths in patients with HF.112

48

Among pharmacologic measures, strong evidence
exists that mineralocorticoid receptor antagonists
(MCRAs) are effective in SD prevention in patients
with HF with low EF and New York Heart
Association (NYHA) functional class II to IV. They
have the same effect in all patients with systolic
dysfunction following an acute MI, regardless of
the existence of signs or symptoms of HF.113 The
most effective methods for SD prevention in
patients with HF are ICD and cardiac
resynchronization therapy defibrillators (CRTD).112 Although HF-related SD is decreasing, many
patients with HF still develop SD and die,
emphasizing new preventive targets such as ANS
imbalance-related brain areas and their functions.
Conclusion
C When one of the two highly-interconnected
organs such as the brain and the heart is affected,
one expects that so will the other, and yet, the bulk
of the SD literature focuses either on the heart or the
brain, but seldom on both. This leaves a large
understudied gap of interactions that might explain
why half of the causes of SD remain unexplained.12
Conceptually, it may be helpful to characterize the
brain-heart relationship as a dynamic balance that
can be altered by extremes of normal function such
as overwhelming emotion, stress, or functional or
structural damage to one of the organs, disrupting
the finely-tuned equilibrium and resulting in
arrhythmia generating imbalances. Many answers
lie in the interphase. Circadian rhythms and the role
of SA may prove important, not only in CVD but
also in stroke.70 The ANS as a therapeutic target in
HF emerges as a promising area of research and
intervention.114 The spectrum of individual
reactivity to stress remains largely unexplored. The
tools for studying these areas continue to become
more available and refined. The development of
sophisticated heart and brain devices to stimulate
and record, the growth of the peering power of
structural and functional imaging, and the
increasing availability of molecular, genetic, and
epigenetic techniques to study gene-environment
interaction115 might yield a more dynamic
understanding of the brain-heart relationship in
health and disease. The availability of smartwatches
with a US Federal Drug Administration (FDA)approved capability to detect AF points to a future
where arrhythmia monitoring and management can
be personalized to minimize the risk of SD. Much
has been achieved in understanding SD, but much
more is needed and can be done.
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